ALL, Childhood B-Cell (1)

Acute Lymphocytic Leukemia Refractory (1)

Acute Lymphoid Leukemia Relapse (1)

Not yet recruiting (1)

phase 1/phase 2 (1)

University Hospital Tuebingen (1)

tafasitamab (1)

biological (1)

Other (1)

Interventional (1)

acute lymphocytic leukemia refractory

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Nov 25, 2022